Dashboard
Manage Tickers

SKYE


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

nasdaq-jumps-over-150-points-skye-bioscience-shares-plunge
Nasdaq Jumps Over 150 Points; Skye Bioscie...
10/06/2025 17:09:01

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
10/06/2025 17:07:04

us-stocks-mixed-dow-falls-100-points
US Stocks Mixed; Dow Falls 100 Points
10/06/2025 15:05:56

skye-biosciences-investigational-drug-disappoints-as-monotherapy-for-weight-loss
Skye Bioscience's Investigational Drug Dis...
10/06/2025 14:39:32

Skye Bioscience'a trial showed nimacimab alone missed goals, while a combo with Novo Nordisk's drug delivered stronger ...

why-amd-shares-are-trading-higher-by-over-34-here-are-20-stocks-moving-premarket
Why AMD Shares Are Trading Higher By Over ...
10/06/2025 13:01:08

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
10/06/2025 12:08:40

Core News & Articles
Skye Bioscience Released Topline Data From...
10/06/2025 11:07:50

In CBeyond, the nimacimab monotherapy arm did not achieve the primary endpoint of weight loss compared to placebo (-1.52% vs. -...

Core News & Articles
HC Wainwright & Co. Initiates Coverage On ...
09/30/2025 11:22:51

HC Wainwright & Co. analyst Ananda Ghosh initiates coverage on Skye Bioscience (NASDAQ:SKYE) with a Buy rating and annou...

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
09/26/2025 21:06:04

Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of t...

could-this-new-drug-be-the-safer-way-to-fight-obesity
Could This New Drug Be The Safer Way To Fi...
09/19/2025 18:19:20

Skye Bioscience reported favorable Phase 1b nimacimab results, with analysts citing strong potential in obesity alongside GLP-1...

Core News & Articles
Skye Presents Phase 1b Data Showing Nimaci...
09/19/2025 11:04:08

skye-bioscience-advances-position-in-competitive-obesity-market-with-promising-data
Skye Bioscience Advances Position In Compe...
09/05/2025 17:35:17

Skye Bioscience's latest data show nimacimab boosted tirzepatide's weight loss effects and reduced obesity treatment re...

Core News & Articles
Skye's Nimacimab Boosts Tirzepatide Result...
09/04/2025 11:10:13

Skye Bioscience, Inc. (NASDAQ:SKYE) ("Skye"), a clinical-stage biotechnology company focused on unlocking new therapeut...

Core News & Articles
Skye Bioscience Announces Completion Of 26...
09/02/2025 11:03:43

Core News & Articles
Evercore ISI Group Initiates Coverage On S...
08/15/2025 17:52:42

Evercore ISI Group analyst Michael DiFiore initiates coverage on Skye Bioscience (NASDAQ:SKYE) with a Outperform rating and ...

Core News & Articles
Skye Bioscience Q2 EPS $(0.44) Misses $(0....
08/07/2025 20:45:06

Skye Bioscience (NASDAQ:SKYE) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

Core News & Articles
JMP Securities Reiterates Market Outperfor...
06/24/2025 13:47:38

JMP Securities analyst Jonathan Wolleben reiterates Skye Bioscience (NASDAQ:SKYE) with a Market Outperform and maintains $15...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
06/23/2025 17:06:33

Core News & Articles
Skye Bioscience Showcases Anti-Obesity Dru...
06/23/2025 11:14:37

Skye Bioscience, Inc. (NASDAQ:SKYE) ("Skye"), a clinical-stage biotechnology company focused on unlocking new therapeut...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION